|
T-peptide TFA,肽类
|
T295006-250mg
|
≥98% |
2022956-62-1 |
250mg
|
¥ 9269.9
|
现货 |
|
0 |
阿拉丁 |
|
T-peptide TFA,肽类
|
T295006-50mg
|
≥98% |
2022956-62-1 |
50mg
|
¥ 2529.9
|
现货 |
|
0 |
阿拉丁 |
|
T-peptide TFA,肽类
|
T295006-10mg
|
≥98% |
2022956-62-1 |
10mg
|
¥ 854.9
|
现货 |
|
0 |
阿拉丁 |
|
四氨合氯化铂一水合物
|
T294931-1g
|
≥99.95% metals basis |
13933-33-0 |
1g
|
¥ 2059.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
三甲基甲基环戊二烯铂(IV)
|
T294870-1g
|
≥99.95% metals basis |
94442-22-5 |
1g
|
¥ 4999.9
|
现货 |
|
0 |
阿拉丁 |
|
十二羰基三钌
|
T294758-5g
|
≥99.95% metals basis |
15243-33-1 |
5g
|
¥ 3697.9
|
现货 |
|
0 |
阿拉丁 |
|
十二羰基三钌
|
T294758-1g
|
≥99.95% metals basis |
15243-33-1 |
1g
|
¥ 1199.9
|
现货 |
|
0 |
阿拉丁 |
|
三环己基膦[1,3-双(2,4,6-三甲基苯基)咪唑-2-亚烷基] [3-苯基-1H-茚-1-基]二氯化钌(II)[catMETium® RF1]
|
T294704-1g
|
≥99.95% metals basis |
254972-49-1 |
1g
|
¥ 4655.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
三环己基膦[1,3-双(2,4,6-三甲基苯基)咪唑-2-亚烷基] [3-苯基-1H-茚-1-基]二氯化钌(II)[catMETium® RF1]
|
T294704-100mg
|
≥99.95% metals basis |
254972-49-1 |
100mg
|
¥ 1297.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
三环己基膦[1,3-双(2,4,6-三甲基苯基)咪唑-2-亚烷基] [2-噻吩基亚甲基]二氯化钌(II) [catMETium® RF 2]
|
T294700-1g
|
≥99.95% metals basis |
1190427-49-6 |
1g
|
¥ 4089.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
三环己基膦[1,3-双(2,4,6-三甲基苯基)咪唑-2-亚烷基] [2-噻吩基亚甲基]二氯化钌(II) [catMETium® RF 2]
|
T294700-100mg
|
≥99.95% metals basis |
1190427-49-6 |
100mg
|
¥ 1143.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
三环己基膦[4,5-二甲基-1,3-双(2,4,6-三甲基苯基)咪唑-2-亚甲基] [2-噻吩基亚甲基]二氯化钌(II)[catMETium® RF 3]
|
T294696-1g
|
≥99.95% metals basis |
1190427-50-9 |
1g
|
¥ 2059.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
单宁酸溶液
|
T291741-250ml
|
Moligand™, 25 grams + 100 mL Waterfor Direct Count for Bacteria, Yeast, and Mold |
1401-55-4 |
250ml
|
¥ 617.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
单宁酸溶液
|
T291741-50ml
|
Moligand™, 25 grams + 100 mL Waterfor Direct Count for Bacteria, Yeast, and Mold |
1401-55-4 |
50ml
|
¥ 205.9
|
现货 |
|
0 |
阿拉丁 |
|
9-(4-叔丁基苯基)-3,6-双(三苯基甲硅烷基)-9H-咔唑
|
T290117-250mg
|
升华级, ≥99% |
898546-82-2 |
250mg
|
¥ 1914.9
|
现货 |
|
0 |
阿拉丁 |
|
9-(4-叔丁基苯基)-3,6-双(三苯基甲硅烷基)-9H-咔唑
|
T290117-50mg
|
升华级, ≥99% |
898546-82-2 |
50mg
|
¥ 581.9
|
现货 |
|
0 |
阿拉丁 |
|
TG 4-155,和EP2受体拮抗剂
|
T288898-100mg
|
Moligand™, ≥98%(HPLC) |
1164462-05-8 |
100mg
|
¥ 6766.9
|
现货 |
|
0 |
阿拉丁 |
|
TG 4-155,和EP2受体拮抗剂
|
T288898-25mg
|
Moligand™, ≥98%(HPLC) |
1164462-05-8 |
25mg
|
¥ 2594.9
|
现货 |
|
0 |
阿拉丁 |
|
TG 4-155,和EP2受体拮抗剂
|
T288898-5mg
|
Moligand™, ≥98%(HPLC) |
1164462-05-8 |
5mg
|
¥ 895.9
|
现货 |
|
0 |
阿拉丁 |
|
沙利度胺 4'-醚-烷基C5-酸
|
T288669-100mg
|
≥95%(HPLC) |
2087490-48-8 |
100mg
|
¥ 3089.9
|
现货 |
|
0 |
阿拉丁 |
|
TH 5487,8-氧鸟嘌呤DNA糖基化酶1(OGG1)抑制剂
|
T288613-25mg
|
Moligand™, ≥98% |
2304947-71-3 |
25mg
|
¥ 499.9
|
现货 |
|
0 |
阿拉丁 |
|
TH 5487,8-氧鸟嘌呤DNA糖基化酶1(OGG1)抑制剂
|
T288613-5mg
|
Moligand™, ≥98% |
2304947-71-3 |
5mg
|
¥ 199.9
|
现货 |
|
0 |
阿拉丁 |
|
TRO 19622,绑定电压依赖性阴离子通道(VDAC)
|
T288490-100mg
|
Moligand™, ≥98%(HPLC) |
22033-87-0 |
100mg
|
¥ 3466.9
|
现货 |
|
0 |
阿拉丁 |
|
TRO 19622,绑定电压依赖性阴离子通道(VDAC)
|
T288490-25mg
|
Moligand™, ≥98%(HPLC) |
22033-87-0 |
25mg
|
¥ 1176.9
|
现货 |
|
0 |
阿拉丁 |